Viewing nowSimvarotin Tablets 20 mg (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Alrico Pharmaceutical Co., Ltd.

MFDS item code 200300639 · Notified 2003.05.31 · Insurance code 656000680
Improvement of hyperlipidemia; treatment of familial hypercholesterolemia in children; prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of mortality from coronary heart disease and the risk of non-fatal myocardial infarction and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral artery disease, and stroke. It also reduces the risk due to vascular interventions. For the treatment of hyperlipidemia, it improves cardiovascular health by controlling cholesterol and triglyceride levels. It is particularly effective in patients with familial hypercholesterolemia or dyslipidemia and is used as an adjunct to dietary therapy. It helps lower total cholesterol and LDL cholesterol levels in pediatric patients with familial hypercholesterolemia. Overall, it is used for managing the risk of cardiovascular diseases.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start at 10 mg of this medicine. It is recommended that 5–40 mg of this medicine be administered once daily in the evening. Before starting treatment, adjust the dose appropriately according to the initial LDL cholesterol level, treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions, 1. Warnings). 2) Refer to the information below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see Precautions, 6. Drug Interactions). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may provide the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is used concomitantly in patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is used concomitantly in patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering drugs This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is used concomitantly with a fibrate (excluding gemfibrozil (see Precautions, 2. Patients who should not receive this medicine) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start treatment at 5 mg daily and monitor carefully.
Pediatric patients aged 10–17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10–40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication helps lower blood cholesterol levels to reduce the risk of cardiovascular disease. When taking this medication, it may cause muscle abnormalities, so if muscle pain, weakness, or tenderness occurs, consult a doctor immediately. Particularly, if taking a high dose of this medication, the risk of serious muscle injury such as myopathy or rhabdomyolysis increases, so caution is necessary. When taken with other medications that interact with this drug, the risk of muscle injury may increase, so be sure to notify your doctor and take appropriate measures. As it may affect liver function, it is better not to take this medication if there is liver disease or abnormal liver function test results. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and those planning a pregnancy should consult a doctor. Patients who consume alcohol excessively, have a history of liver or kidney disease, have hypothyroidism, or are elderly or female should be especially cautious when taking this medication. Regular blood tests are recommended to monitor liver function and muscle-related indicators while taking this medication. Avoid grapefruit juice as it may increase blood concentration and risk of side effects. If a new medication is prescribed or taken while using this medication, inform the prescribing doctor or pharmacist about the medications being taken. In case of overdose, visit a medical facility immediately for appropriate treatment and store the medication out of reach of children.
Myopathy, rhabdomyolysis, abdominal pain, weakness, constipation, diarrhea, dyspepsia, bloating, nausea, headache, upper respiratory infection, edema, atrial fibrillation, gastritis, diabetes, myalgia, insomnia, dizziness, bronchitis, sinusitis, eczema, urinary tract infection, elevated aminotransferase levels, hepatitis, pancreatitis, hepatic failure, cholestatic jaundice, fatty liver changes, cirrhosis, fulminant hepatic necrosis, hepatocellular carcinoma, loss of appetite, vomiting, alopecia, pruritus, skin changes, lichenoid drug rash, gynecomastia, decreased libido, sexual dysfunction, cataract progression, ophthalmoplegia, anemia, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, peripheral neuropathy, thrombocytopenia, hypersensitivity syndrome, interstitial lung disease, lupus-like syndrome, vasculitis, purpura, thrombocytopenic purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, eosinophilia, arthritis, arthralgia, urticaria, photosensitivity, fever, chills, flushing, fatigue, dyspnea, toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, muscle cramps, arthralgia, specific cranial nerve dysfunction, taste disturbances, external ocular muscle disorders, facial incomplete paralysis, tremors, sensory disturbances, peripheral neuropathy, peripheral nerve palsy, psychiatric disorders, anxiety, sleep disorders, nightmares, depression, cognitive impairment, myasthenia gravis, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture from entering, at room temperature between 1°C and 30°C. This way of storage can help maintain the efficacy of the medication.
Brownish-yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Alrico Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.